The global RSV Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for RSV Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for RSV Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for RSV Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key RSV Vaccine players cover Pfizer, GSK, Moderna, JNJ, Bavarian Nordic, Nuance Pharma and Advaccine, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “RSV Vaccine Industry Forecast” looks at past sales and reviews total world RSV Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected RSV Vaccine sales for 2023 through 2029. With RSV Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RSV Vaccine industry.
This Insight Report provides a comprehensive analysis of the global RSV Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on RSV Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global RSV Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RSV Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RSV Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of RSV Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Clinical I
Clinical II
Clinical III
Preclinical
Being Developed
Segmentation by application
Elderly Vaccine
Infant Vaccine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
GSK
Moderna
JNJ
Bavarian Nordic
Nuance Pharma
Advaccine
Key Questions Addressed in this Report
What is the 10-year outlook for the global RSV Vaccine market?
What factors are driving RSV Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do RSV Vaccine market opportunities vary by end market size?
How does RSV Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global RSV Vaccine Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for RSV Vaccine by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for RSV Vaccine by Country/Region, 2018, 2022 & 2029 2.2 RSV Vaccine Segment by Type 2.2.1 Clinical I 2.2.2 Clinical II 2.2.3 Clinical III 2.2.4 Preclinical 2.2.5 Being Developed 2.3 RSV Vaccine Sales by Type 2.3.1 Global RSV Vaccine Sales Market Share by Type (2018-2023) 2.3.2 Global RSV Vaccine Revenue and Market Share by Type (2018-2023) 2.3.3 Global RSV Vaccine Sale Price by Type (2018-2023) 2.4 RSV Vaccine Segment by Application 2.4.1 Elderly Vaccine 2.4.2 Infant Vaccine 2.4.3 Others 2.5 RSV Vaccine Sales by Application 2.5.1 Global RSV Vaccine Sale Market Share by Application (2018-2023) 2.5.2 Global RSV Vaccine Revenue and Market Share by Application (2018-2023) 2.5.3 Global RSV Vaccine Sale Price by Application (2018-2023) 3 Global RSV Vaccine by Company 3.1 Global RSV Vaccine Breakdown Data by Company 3.1.1 Global RSV Vaccine Annual Sales by Company (2018-2023) 3.1.2 Global RSV Vaccine Sales Market Share by Company (2018-2023) 3.2 Global RSV Vaccine Annual Revenue by Company (2018-2023) 3.2.1 Global RSV Vaccine Revenue by Company (2018-2023) 3.2.2 Global RSV Vaccine Revenue Market Share by Company (2018-2023) 3.3 Global RSV Vaccine Sale Price by Company 3.4 Key Manufacturers RSV Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers RSV Vaccine Product Location Distribution 3.4.2 Players RSV Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for RSV Vaccine by Geographic Region 4.1 World Historic RSV Vaccine Market Size by Geographic Region (2018-2023) 4.1.1 Global RSV Vaccine Annual Sales by Geographic Region (2018-2023) 4.1.2 Global RSV Vaccine Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic RSV Vaccine Market Size by Country/Region (2018-2023) 4.2.1 Global RSV Vaccine Annual Sales by Country/Region (2018-2023) 4.2.2 Global RSV Vaccine Annual Revenue by Country/Region (2018-2023) 4.3 Americas RSV Vaccine Sales Growth 4.4 APAC RSV Vaccine Sales Growth 4.5 Europe RSV Vaccine Sales Growth 4.6 Middle East & Africa RSV Vaccine Sales Growth 5 Americas 5.1 Americas RSV Vaccine Sales by Country 5.1.1 Americas RSV Vaccine Sales by Country (2018-2023) 5.1.2 Americas RSV Vaccine Revenue by Country (2018-2023) 5.2 Americas RSV Vaccine Sales by Type 5.3 Americas RSV Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC RSV Vaccine Sales by Region 6.1.1 APAC RSV Vaccine Sales by Region (2018-2023) 6.1.2 APAC RSV Vaccine Revenue by Region (2018-2023) 6.2 APAC RSV Vaccine Sales by Type 6.3 APAC RSV Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe RSV Vaccine by Country 7.1.1 Europe RSV Vaccine Sales by Country (2018-2023) 7.1.2 Europe RSV Vaccine Revenue by Country (2018-2023) 7.2 Europe RSV Vaccine Sales by Type 7.3 Europe RSV Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa RSV Vaccine by Country 8.1.1 Middle East & Africa RSV Vaccine Sales by Country (2018-2023) 8.1.2 Middle East & Africa RSV Vaccine Revenue by Country (2018-2023) 8.2 Middle East & Africa RSV Vaccine Sales by Type 8.3 Middle East & Africa RSV Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of RSV Vaccine 10.3 Manufacturing Process Analysis of RSV Vaccine 10.4 Industry Chain Structure of RSV Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 RSV Vaccine Distributors 11.3 RSV Vaccine Customer 12 World Forecast Review for RSV Vaccine by Geographic Region 12.1 Global RSV Vaccine Market Size Forecast by Region 12.1.1 Global RSV Vaccine Forecast by Region (2024-2029) 12.1.2 Global RSV Vaccine Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global RSV Vaccine Forecast by Type 12.7 Global RSV Vaccine Forecast by Application 13 Key Players Analysis 13.1 Pfizer 13.1.1 Pfizer Company Information 13.1.2 Pfizer RSV Vaccine Product Portfolios and Specifications 13.1.3 Pfizer RSV Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Pfizer Main Business Overview 13.1.5 Pfizer Latest Developments 13.2 GSK 13.2.1 GSK Company Information 13.2.2 GSK RSV Vaccine Product Portfolios and Specifications 13.2.3 GSK RSV Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 GSK Main Business Overview 13.2.5 GSK Latest Developments 13.3 Moderna 13.3.1 Moderna Company Information 13.3.2 Moderna RSV Vaccine Product Portfolios and Specifications 13.3.3 Moderna RSV Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Moderna Main Business Overview 13.3.5 Moderna Latest Developments 13.4 JNJ 13.4.1 JNJ Company Information 13.4.2 JNJ RSV Vaccine Product Portfolios and Specifications 13.4.3 JNJ RSV Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 JNJ Main Business Overview 13.4.5 JNJ Latest Developments 13.5 Bavarian Nordic 13.5.1 Bavarian Nordic Company Information 13.5.2 Bavarian Nordic RSV Vaccine Product Portfolios and Specifications 13.5.3 Bavarian Nordic RSV Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Bavarian Nordic Main Business Overview 13.5.5 Bavarian Nordic Latest Developments 13.6 Nuance Pharma 13.6.1 Nuance Pharma Company Information 13.6.2 Nuance Pharma RSV Vaccine Product Portfolios and Specifications 13.6.3 Nuance Pharma RSV Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Nuance Pharma Main Business Overview 13.6.5 Nuance Pharma Latest Developments 13.7 Advaccine 13.7.1 Advaccine Company Information 13.7.2 Advaccine RSV Vaccine Product Portfolios and Specifications 13.7.3 Advaccine RSV Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Advaccine Main Business Overview 13.7.5 Advaccine Latest Developments 14 Research Findings and Conclusion